A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

Longevity researchers say the biggest predictors of healthy aging aren't found in a bottle. Decades of research suggest that ...

The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.

Researchers at the University of Münster and Ruhr University Bochum have demonstrated for the first time in real time that the body's own defense cells use catecholamines—neurotransmitters such as ...

There is a constant war going on in your body. Working against you are viruses and cancer cells growing uncontrollably, threatening your tissues and organs. Fighting on your side are immune cells such ...

Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

Health authorities in the Democratic Republic of Congo have launched a large-scale clinical trial of an experimental Ebola treatment in a move ...

A defense system that cannot distinguish friend from stranger eventually harms the organization it is supposed to protect.

It is increasingly recognized that galactose-deficient IgA in the glomerulus activates the alternative complement system and drives IgA nephropathy, including in the tubules and interstitium, leading ...

Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and ...

In 1939, he repeatedly placed dog ticks on guinea pigs and watched something change. After the first round of bites, the ...

Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative therapies for the treatment of immune complement-related conditions and ...